MAGELLAN LONGEVITY
HomeResearchStudy library › Effects of Spermidine Supplementation on Cognition and Biomarkers in…
Study summary · Brain, cognition & mood

Does longer-term spermidine supplementation affect memory performance and biomarkers in older adults with subjective cognitive decline?

In one paragraph

Spermidine, a randomized controlled trial (JAMA Netw Open 2022, PMID 35616942) — longer-term spermidine supplementation (0.9 mg/d) did not significantly improve memory or biomarkers in older adults with subjective cognitive decline compared to placebo. Over 12 months, no significant changes were observed in mnemonic discrimination performance (between-group difference, -0.03; 95% CI, -0.11 to 0.05; P =.47) or secondary outcomes.

Source: JAMA Netw Open 2022, PMID 35616942 ↗ · Research map · How Magellan grades evidence · evidence confidence: high

JAMA Netw Open · 2022 · PMID 35616942 · DOI 10.1001/jamanetworkopen.2022.13875

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

A 12-month daily spermidine supplement did not improve memory or biomarkers in older adults with subjective cognitive decline, though exploratory findings suggest possible benefits for verbal memory and inflammation.

The question

Does longer-term spermidine supplementation affect memory performance and biomarkers in older adults with subjective cognitive decline?

What they tested

Spermidine supplementation will show beneficial effects on memory performance and biomarkers in older adults with subjective cognitive decline, based on prior animal studies and preliminary human evidence.

How they did it

This was a 12-month randomized, double-masked, placebo-controlled phase 2b trial (SmartAge trial) conducted at a single academic clinical research center in Germany. One hundred participants aged 60 to 90 years with subjective cognitive decline were randomly assigned (1:1) to receive either 0.9 mg/d of a spermidine-rich wheat germ extract or placebo (microcrystalline cellulose). The primary outcome was the change in mnemonic discrimination performance from baseline to 12 months, assessed by the Mnemonic Similarity Task. Secondary outcomes included other neuropsychological, behavioral, and physiological parameters, with safety also assessed.

What they found

A total of 100 participants (51 in the spermidine group, 49 in the placebo group; mean age 69 years; 49% female) were included in the analysis. Over 12 months, no significant changes were observed in mnemonic discrimination performance (between-group difference, -0.03; 95% CI, -0.11 to 0.05; P = .47) or secondary outcomes. Exploratory analyses suggested possible beneficial effects on inflammation and verbal memory. Adverse events were balanced between the groups.

What it means

Longer-term spermidine supplementation (0.9 mg/d) did not significantly improve memory or biomarkers in older adults with subjective cognitive decline compared to placebo. Exploratory findings on verbal memory and inflammation require validation in future studies, potentially with higher dosages.

Limitations

The study was a monocenter trial, and the dosage of spermidine (0.9 mg/d) might have been insufficient to elicit significant effects. The observed beneficial effects on verbal memory and inflammation were exploratory and require further validation.

“exploratory analyses indicated possible beneficial effects on verbal memory and inflammation”— from the published abstract, JAMA Netw Open 2022

The paper at a glance

TitleEffects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial
JournalJAMA Netw Open
Year2022
PMID35616942 ↗
DOI10.1001/jamanetworkopen.2022.13875 ↗
TopicBrain, cognition & mood

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Spermidine (Wheat-Germ Extract)

In model organisms (yeast, worms, flies and mice) spermidine induces autophagy and extends lifespan, and in rodents it reduces age-related cardiac dysfunction and blood pressure and improves memory. Human evidence is earlier-stage and genuinely mixed.

Spermidine (Wheat-Germ Extract)

Spermidine is a naturally occurring polyamine present in all human cells and obtained from the diet…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Does longer-term spermidine supplementation affect memory performance and biomarkers in older adults with subjective cognitive decline? [Plain-English summary of JAMA Netw Open 2022, PMID 35616942, DOI 10.1001/jamanetworkopen.2022.13875]. Magellan Longevity. https://magellanlongevity.com/study/x3.html
BibTeX
@misc{magellan_x3, title = {Does longer-term spermidine supplementation affect memory performance and biomarkers in older adults with subjective cognitive decline?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/x3.html}}, note = {Plain-English summary of PubMed PMID 35616942; DOI 10.1001/jamanetworkopen.2022.13875; JAMA Netw Open 2022. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/x3.html

Related studies in the Magellan library

All 26 Magellan summaries on brain, cognition & mood →

How this summary was made. Every section above restates what the published abstract of PMID 35616942 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.